title: Isodicentric duplication of Philadelphia chromosome as a mechanism of resistance to dasatinib in a patient with chronic myeloid leukemia after resistance to imatinib.
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Loglisci
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
authors.forename: Mauro
authors.initials: M
authors.lastname: Nanni
authors.forename: Marco
authors.initials: M
authors.lastname: Mancini
authors.forename: Rosa
authors.initials: R
authors.lastname: De Cuia
authors.forename: Laura
authors.initials: L
authors.lastname: Cannella
authors.forename: Adriano
authors.initials: A
authors.lastname: Salaroli
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Federico
authors.forename: Alessandra
authors.initials: A
authors.lastname: Serrao
authors.forename: Maria Giovanna
authors.initials: MG
authors.lastname: Loglisci
authors.forename: Michelina
authors.initials: M
authors.lastname: Santopietro
authors.forename: Giuliana
authors.initials: G
authors.lastname: Alimena
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D002871:Chromosome Banding; D058674:Chromosome Duplication / Q000235:genetics*; D000069439:Dasatinib; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000235:genetics; D010677:Philadelphia Chromosome; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use*; D013844:Thiazoles / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D000068877:Imatinib Mesylate; D000069439:Dasatinib